Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo. Sharing a Mounjaro pen with another person is not safe and is not permitted. Each pre-filled KwikPen is prescribed for one individual, calibrated to their clinical assessment and dose stage. Even if the pen looks unused, sharing it risks transferring bloodborne infections and exposes the second person to a medicine their own prescriber has never assessed them for. This is an important safety point about Mounjaro that applies regardless of how much of the pen appears to remain.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This question comes up more often than you might expect, especially among couples or housemates who are both on weight-loss treatment and trying to manage costs. The concern is real, but the risk is just as real.
A Mounjaro KwikPen is designed so that each press of the button delivers one weekly dose. Between uses, the pen sits in the fridge, usually on the fridge door alongside other everyday items. That storage routine feels domestic and low-risk. It isn't, from a sharing perspective.
The issue is not just the needle. Attaching a brand-new needle before every injection is already the correct practice, as NHS guidance on tirzepatide makes clear, and if you are ever unsure about the process, our guide on how to remove a Mounjaro needle safely walks you through each step. But the needle is only the external contact point. The internal cannula of the pen can draw a tiny amount of blood back into the device during or after an injection, a process called backflow contamination. A replacement needle on the outside does nothing to remove that. Passing the pen to a second person therefore carries a genuine risk of transmitting bloodborne infections including hepatitis B, hepatitis C and HIV.
Eli Lilly, who manufacture Mounjaro, state explicitly in the pen's Patient Information Leaflet that the pen must never be shared, even with a new needle attached. The same principle applies across all multi-dose injection devices. There are no exceptions for family members, no exceptions for people on the same dose, and no exceptions for a pen that has only been used once.
It is understandable to think of it as a short-term fix. If a partner is prescribed the same dose and the pen looks identical, the logic seems harmless. It isn't, for two separate reasons.
First, the contamination risk described above applies from the very first injection. Second, a prescription is issued to a named individual following a clinical assessment of that specific person. Taking medicine prescribed to someone else means using a dose and a product that a prescriber reviewed for someone else's weight, health history and current medications, not yours. What suits one person may genuinely not suit another, even at the same dose. You can read more about the specific risks of using a shared Mounjaro pen in our detailed safety guide.
There is also a practical issue: a pen's shelf life once removed from the fridge is limited. If the pen you have borrowed has been out of refrigeration for any significant period, its potency may already be reduced, and you would have no way of knowing.
If you have genuinely run out of your own treatment, contact your prescriber the same day. Do not attempt to bridge the gap with someone else's pen.
Circumstances change. You might be advised to pause treatment temporarily, switch to a different dose, or stop for a medical reason. When that happens, some weekly doses may still remain in your current pen.
Those remaining doses should not be offered to anyone else. The correct step is safe disposal. The pen (with its current needle removed and capped, or with the pen cap replaced) should go into a sharps container, not a household bin or recycling. Opening the Mounjaro pen to remove the cartridge is not recommended either; the mechanism is designed to be used as a unit and disposed of as one.
Your local pharmacy or GP surgery will usually accept sharps containers for disposal, or your local council may run a collection service. The MHRA's Yellow Card scheme is the right channel if you have concerns about a product's quality or suspect a pen may not be genuine, worth knowing if you are sourcing treatment privately.
No. The prescription and the pen belong to one person. Two people cannot share one pen to halve their costs, regardless of whether both hold their own valid prescriptions for the same dose. Each person needs their own pen, dispensed against their own prescription, reviewed by their own prescriber.
Cost is a legitimate concern with private Mounjaro treatment. The right way to manage it is to understand exactly what a responsible provider includes in the price (consultation, clinical review, delivery and aftercare) rather than to compromise the safety of the medicine itself. Our weight-loss treatment page sets out what the process looks like at nume, from the initial free consultation through to ongoing prescriber support.
If you have questions about how injection technique affects safety and comfort, our guide on Mounjaro injection sites covers the practical detail. And if you are new to the pen altogether, how the Mounjaro KwikPen works is a sensible place to start before your first dose.
Speak to our prescribers if you have any questions about managing your treatment safely between doses, same-day clinical review means you won't be left without an answer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.